319 related articles for article (PubMed ID: 23108548)
41. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N
Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540
[TBL] [Abstract][Full Text] [Related]
42. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages.
Jiang LS; Pu J; Han ZH; Hu LH; He B
Cardiovasc Res; 2009 Mar; 81(4):805-13. PubMed ID: 19074161
[TBL] [Abstract][Full Text] [Related]
43. Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.
Chen L; Zhang J; Li F; Qiu Y; Wang L; Li YH; Shi J; Pan HL; Li M
J Pain; 2009 Jul; 10(7):732-9. PubMed ID: 19409856
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of endocannabinoids.
Biernacki M; Skrzydlewska E
Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):830-43. PubMed ID: 27516570
[TBL] [Abstract][Full Text] [Related]
45. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
46. Targeting the cannabinoid system for pain relief?
Chiou LC; Hu SS; Ho YC
Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
[TBL] [Abstract][Full Text] [Related]
47. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
Guindon J; Guijarro A; Piomelli D; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
[TBL] [Abstract][Full Text] [Related]
48. Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity.
Brocato B; Zoerner AA; Janjetovic Z; Skobowiat C; Gupta S; Moore BM; Slominski A; Zhang J; Schenone M; Phinehas R; Ferry RJ; Dick E; Hubbard GB; Mari G; Schlabritz-Loutsevitch N
Placenta; 2013 Nov; 34(11):983-9. PubMed ID: 24008071
[TBL] [Abstract][Full Text] [Related]
49. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
[TBL] [Abstract][Full Text] [Related]
50. Endocannabinoid-mediated retrograde modulation of synaptic transmission.
Ohno-Shosaku T; Kano M
Curr Opin Neurobiol; 2014 Dec; 29():1-8. PubMed ID: 24747340
[TBL] [Abstract][Full Text] [Related]
51. Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice.
Gould GG; Seillier A; Weiss G; Giuffrida A; Burke TF; Hensler JG; Rock C; Tristan A; McMahon LR; Salazar A; O'Connor JC; Satsangi N; Satsangi RK; Gu TT; Treat K; Smolik C; Schultz ST
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):260-9. PubMed ID: 22542870
[TBL] [Abstract][Full Text] [Related]
52. Endocannabinoid metabolism by cytochrome P450 monooxygenases.
Zelasko S; Arnold WR; Das A
Prostaglandins Other Lipid Mediat; 2015; 116-117():112-23. PubMed ID: 25461979
[TBL] [Abstract][Full Text] [Related]
53. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
Hutch CR; Hillard CJ; Jia C; Hegg CC
Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
[TBL] [Abstract][Full Text] [Related]
54. Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
Manduca A; Morena M; Campolongo P; Servadio M; Palmery M; Trabace L; Hill MN; Vanderschuren LJ; Cuomo V; Trezza V
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1362-74. PubMed ID: 25914159
[TBL] [Abstract][Full Text] [Related]
55. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S
Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103
[TBL] [Abstract][Full Text] [Related]
56. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
[TBL] [Abstract][Full Text] [Related]
57. The endocannabinoid system expression in the female reproductive tract is modulated by estrogen.
Maia J; Almada M; Silva A; Correia-da-Silva G; Teixeira N; Sá SI; Fonseca BM
J Steroid Biochem Mol Biol; 2017 Nov; 174():40-47. PubMed ID: 28743542
[TBL] [Abstract][Full Text] [Related]
58. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
59. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
[TBL] [Abstract][Full Text] [Related]
60. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
